Predictive metabolic networks reveal sex‐ and <i>APOE</i> genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease

Abstract

These findings provide an initial but critical step in developing a diagnostic platform for personalized medicine by integrating metabolomic profiling and cognitive assessments to identify targeted precision therapeutics for AD patient subgroups through computational network modeling.